Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Vishay Launches TANTAMOUNT® Solid Tantalum Chip Capacitors

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
Reliable molded capacitors combine robust anode design with Weibull grading and Hi-Rel screening options.

Vishay Intertechnology, Inc. has introduced a new series of TANTAMOUNT® surface-mount solid tantalum molded chip capacitors designed to provide improved performance and reliability in a wide variety of non-life-support medical monitoring and diagnostic instruments for in-home and hospital use.

Featuring a robust anode design, the TM3 series is 100 % surge current tested (B, C, D, and E case sizes) and available with Weibull grading and Hi-Rel screening options.

Vishay manufactures the new TM3 series at its Dimona, Israel, manufacturing facility. In addition to being ISO9001-certified, the Dimona plant was recently certified to ISO13485 standards, which outline medical device regulatory requirements for quality management systems and facilitate the requirements needed for medical device regulatory compliance by the U.S. Food and Drug Administration.

The Vishay Sprague TM3 devices released are optimized for input capacitor filters on DC/DC converters, hot plugging surges on battery chargers, low-drop-out devices, and capacitor charge pumps.

Typical end products will include glucose meters, infusion pumps, nebulizers, and thermometers.

TM3 devices are offered in a molded package in five standard EIA-535BAAC case codes: A, B, C, D, and E. The capacitors provide a capacitance range from 1 µF to 220 µF over voltage ratings from 4 V to 20 V; capacitance tolerances of ± 10 % and ± 20 %; high ripple current carrying capability to 11 A; and an operating temperature range of -55 °C to +125 °C with voltage derating.

RoHS-compliant and halogen-free, the TM3 series is available with 100 % matte tin or tin/lead terminations. The devices are compatible with high-volume automatic pick-and-place equipment, and their dry packaging is compliant to the JEDEC-033 standard.

Samples and production quantities of the new TM3 series are available now, with lead times of 12 weeks for larger orders.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Biomarker Finder Adjusts On the Fly
Rice University scientists build better tool to find signs of disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos